Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer

• Asıl Yazarlar: Marianne J. Rutten (Yazar), Gabe S. Sonke (Yazar), Anneke M. Westermann (Yazar), Willemien J. van Driel (Yazar), Johannes W. Trum (Yazar), Gemma G. Kenter (Yazar), Marrije R. Buist (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Hindawi Limited, 2015-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Although complete debulking surgery for epithelial ovarian cancer (EOC) is more often achieved with interval debulking surgery (IDS) following neoadjuvant chemotherapy (NACT), randomized evidence shows no long-term survival benefit compared to complete primary debulking surgery (PDS). We performed a...